Caj Haglund

CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

Monika Carpelan‐Holmström, Johanna Louhimo, Ulf‐Håkan Stenman et al. · PubMed · 2002 · 222 citations

Medicine, Oncology, Pathology +16

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

Hannu Jalanko, Pentti Kuusela, Peter Roberts‎ et al. · Journal of Clinical Pathology · 1984 · 160 citations · Full text

Medicine, Oncology, Pathology +17

Effect of intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy

B. Scheinin, Ilmo Kellokumpu, L. Lindgren et al. · Acta Anaesthesiologica Scandinavica · 1995 · 132 citations

Medicine, Anesthesiology, Surgery +14

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer

Caj Haglund, Peter Roberts‎, Pentti Kuusela et al. · British Journal of Cancer · 1986 · 128 citations · Full text

Medicine, Oncology, Pathology +11

Tumour marker antigen CA125 in pancreatic cancer: A comparison with CA19-9 and CEA

Caj Haglund · British Journal of Cancer · 1986 · 109 citations · Full text

Medicine, Oncology, Pathology +10